We are live on ! Find out more
RBC

Ronald Blue & Co Portfolio holdings

AUM $3.1B
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
+1.36%
1 Year Est. Return
+12.82%
3 Year Est. Return
+2.44%
5 Year Est. Return
10 Year Est. Return
AUM
$1.37B
AUM Growth
+$25.2M
Cap. Flow
+$8.31M
Cap. Flow %
0.61%
Top 10 Hldgs %
82.81%
Holding
358
New
53
Increased
154
Reduced
110
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 2.69%
2 Financials 2.35%
3 Energy 2.17%
4 Industrials 2.14%
5 Consumer Staples 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
101
Kimberly-Clark
KMB
$36.3B
$747K 0.05%
7,064
+33
+0.5% +$3.42K
VALE icon
102
Vale
VALE
$64.1B
$741K 0.05%
53,551
+10,969
+26% +$150K
CSCO icon
103
Cisco
CSCO
$457B
$733K 0.05%
32,738
+733
+2% +$16.2K
GILD icon
104
Gilead Sciences
GILD
$162B
$732K 0.05%
10,333
+2,032
+24% +$159K
MON
105
DELISTED
Monsanto Co
MON
$729K 0.05%
6,413
+143
+2% +$15.9K
GLD icon
106
SPDR Gold Trust
GLD
$131B
$728K 0.05%
5,892
-16,475
-74% -$2.05M
HD icon
107
Home Depot
HD
$331B
$727K 0.05%
9,192
-62
-0.7% -$4.93K
ABT icon
108
Abbott
ABT
$183B
$716K 0.05%
18,595
+430
+2% +$16.6K
DD icon
109
DuPont de Nemours
DD
$18.5B
$712K 0.05%
5,791
+128
+2% +$15.1K
NEE icon
110
NextEra Energy
NEE
$181B
$710K 0.05%
29,688
+972
+3% +$22K
UN
111
DELISTED
Unilever NV New York Registry Shares
UN
$703K 0.05%
17,095
+1,744
+11% +$67.8K
AFL icon
112
Aflac
AFL
$64.9B
$701K 0.05%
+22,236
New +$707K
BMY icon
113
Bristol-Myers Squibb
BMY
$133B
$700K 0.05%
13,473
-3,309
-20% -$176K
VOE icon
114
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$696K 0.05%
8,400
+1,314
+19% +$105K
BKNG icon
115
Booking.com
BKNG
$149B
$692K 0.05%
14,500
-1,325
-8% -$65.4K
USB icon
116
US Bancorp
USB
$98.2B
$684K 0.05%
15,953
+621
+4% +$25.5K
TEVA icon
117
Teva Pharmaceuticals
TEVA
$40.8B
$668K 0.05%
12,636
-549
-4% -$25.4K
AXP icon
118
American Express
AXP
$227B
$658K 0.05%
7,311
-134
-2% -$12K
TFCFA
119
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$656K 0.05%
20,529
-278
-1% -$9.09K
ORCL icon
120
Oracle
ORCL
$374B
$650K 0.05%
15,908
+3,708
+30% +$141K
IGSB icon
121
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$646K 0.05%
12,246
-32,098
-72% -$1.69M
ARMH
122
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$644K 0.05%
12,637
+2,306
+22% +$112K
GSK icon
123
GSK
GSK
$104B
$642K 0.05%
9,616
+1,106
+13% +$74.8K
BIIB icon
124
Biogen
BIIB
$30B
$630K 0.05%
2,061
-27
-1% -$8.57K
SBUX icon
125
Starbucks
SBUX
$120B
$630K 0.05%
17,180
+2,962
+21% +$110K

Similar funds

Ronald Blue & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Ronald Blue & Co held 358 positions worth $1.37B, up 1.9% from $1.35B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Ronald Blue & Co's Q1 2014 filing shows 53 new, 154 increased, 110 reduced and 26 closed positions. Its largest new stake was Vident US Equity Strategy ETF: 1,884,215 shares worth $48.3M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $74.3M.

By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, up from 2.5% a quarter earlier, followed by Financials and Energy.

  • Ronald Blue & Co's largest Q1 2014 buy was Vident US Equity Strategy ETF: 1,884,215 shares worth $48.3M.
  • Ronald Blue & Co added most to Vident International Equity Strategy in Q1 2014, an estimated $157M increase.
  • Ronald Blue & Co's biggest Q1 2014 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $74.3M.
  • Ronald Blue & Co fully exited Alphabet (Google) Class C in Q1 2014, selling an estimated $1.58M.
  • Ronald Blue & Co's ten largest holdings make up 83% of its $1.37B portfolio in Q1 2014.
  • Ronald Blue & Co opened 53 new positions and closed 26 in Q1 2014.
  • Ronald Blue & Co's portfolio value rose 1.9% quarter-over-quarter to $1.37B.

Based on Ronald Blue & Co's 13F filing for Q1 2014, filed 13 May 2014.